Latest News

21

May 2019

First sublingual ketamine drug for treatment of acute pain to be evaluated in end-of-phase 2 meeting with FDA

Read On

09

May 2019

iX Biopharma Ltd. has reported results for the third financial quarter and nine months ended 31st March 2019...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com